Skip to main content

Table 1 Patient and treatment demographics of long-term survivors

From: Thirty-three long-term survivors after cytoreductive surgery in patients with peritoneal metastases from colorectal cancer: a retrospective descriptive study

Case no.

Age

Gender

Onset of

Primary tumor

Histology

Lymph node

KRAS

BRAF

PCI

CCR

HIPEC

Postoperative

Preoperative

Postoperative

PM

Location

Metastasis

Mutation

Mutation

at CRS

at CRS

Complication (G ≥ III)

CT

CT

1

67

F

Metachronous

Left

sig

Negative

WT

WT

4

0

5-FU + OX

None

Modern CT, IP

Not done

2

66

F

Metachronous

Right

tub

Positive

NE

NE

5

0

CDDP+MMC

Intraabdominal

Modern CT

Modern CT

3

50

F

Metachronous

Right

tub

Negative

WT

WT

4

0

5-FU + OX

None

Modern CT

5-FU

4

65

F

Metachronous

Left

muc

Positive

Mutated

NE

16

0

Not done

None

IP

5-FU

5

71

F

Metachronous

Right

sig

Positive

WT

NE

5

0

CDDP+MMC

None

Modern CT

Modern CT

6

50

M

Metachronous

Left

tub

Positive

WT

WT

7

0

CDDP+MMC

None

5-FU

Modern CT

7

66

F

Metachronous

Left

tub

Positive

Mutated

NE

1

0

CDDP+MMC

None

5-FU

5-FU

8

48

F

Metachronous

Left

tub

Positive

WT

NE

6

0

CDDP+MMC

Extraabdominal

5-FU

Modern CT

9

57

F

Metachronous

Right

tub

Positive

NE

NE

4

0

CDDP+MMC

None

Modern CT

5-FU

10

74

M

Synchronous

Right

muc

Negative

NE

NE

12

0

Not done

None

5-FU

5-FU

11

59

M

Metachronous

Left

tub

Positive

WT

NE

10

0

5-FU + OX

None

Modern CT

5-FU

12

63

M

Metachronous

Left

tub

Negative

WT

NE

2

0

Not done

None

Modern CT

Modern CT

13

61

F

Metachronous

Right

tub

Positive

NE

NE

3

0

CDDP+MMC

None

Modern CT

Modern CT

14

47

M

Metachronous

Right

tub

Negative

WT

NE

3

0

CDDP+MMC

None

Modern CT

5-FU

15

59

F

Metachronous

Left

tub

Positive

NE

NE

1

0

5-FU + OX

None

Modern CT

Modern CT

16

69

F

Metachronous

Left

muc

Negative

NE

NE

12

0

CDDP+MMC

Intraabdominal

IP

5-FU

17

36

F

Synchronous

Right

muc

Negative

WT

WT

27

0

CDDP+MMC

Extraabdominal

Modern CT

5-FU

18

48

M

Synchronous

Left

tub

Positive

NE

NE

2

0

CDDP+MMC

None

Not done

Not done

19

35

M

Synchronous

Left

tub

Positive

NE

NE

2

0

5-FU + MMC

None

Modern CT

Modern CT

20

72

F

Metachronous

Right

tub

Positive

NE

NE

2

0

5-FU + OX

None

Modern CT

5-FU

21

66

F

Metachronous

Left

tub

Negative

NE

NE

2

0

Not done

None

Modern CT

5-FU

22

57

F

Synchronous

Right

tub

Positive

WT

WT

2

0

CDDP+MMC

None

Modern CT

Modern CT

23

75

F

Metachronous

Left

tub

Positive

Mutated

NE

3

0

5-FU + OX

None

5-FU

5-FU

24

67

M

Metachronous

Left

tub

Negative

NE

NE

4

0

Not done

Intraabdominal

Modern CT

Not done

25

49

M

Metachronous

Right

tub

Positive

NE

NE

4

0

5-FU + OX

None

Modern CT

Not done

26

66

M

Metachronous

Left

tub

Positive

NE

NE

4

0

Not done

None

Not done

Not done

27

58

F

Metachronous

Left

tub

Positive

NE

NE

8

0

Not done

None

Modern CT

Modern CT

28

62

F

Metachronous

Right

tub

Positive

Mutated

NE

4

0

CDDP+MMC

None

Modern CT

5-FU

29

37

F

Metachronous

Right

muc

Negative

WT

NE

2

0

CDDP+MMC

None

Modern CT

5-FU

30

33

M

Metachronous

Right

muc

Negative

NE

NE

1

0

CDDP+MMC

None

Modern CT

Modern CT

31

59

F

Synchronous

Right

muc

Positive

NE

NE

3

0

CDDP+MMC

None

IP

5-FU

32

33

M

Metachronous

Right

tub

Negative

NE

NE

1

0

CDDP+MMC

None

5-FU, IP

5-FU

33

57

F

Synchronous

Right

tub

Positive

NE

NE

2

0

CDDP+MMC

None

Modern CT

Modern CT

  1. Abbreviations: CCR completeness of cytoreduction, CDDP cisplatin, CRS cytoreductive surgery, CT chemotherapy, F female, HIPEC hyperthermic intraperitoneal chemotherapy, IP intraperitoneal chemotherapy, Left** left-sided colon, M male, MMC mitomycin C, muc mucinous adenocarcinoma, NE not examined, no. number, OX oxaliplatin, PCI peritoneal cancer index, Right* right-sided colon, sig signet ring cell carcinoma, tub well to moderately differentiated tubular adenocarcinoma, WT wild type
  2. *Right represents the right-sided colon cancer defined as any tumor in the cecum, ascending colon, and transverse colon
  3. **Left represents the left-sided colon cancer defined as any tumor in the descending colon and sigmoid colon